Final results of the Minnie Pearl Cancer Research Network first-line trial of weekly paclitaxel/carboplatin/trastuzumab in metastatic breast cancer.

被引:0
|
作者
Yardley, DA
Greco, FA
Hainsworth, JD
Houston, GA
Broome, CM
Bramham, J
Patton, JF
Thompson, DS
Erland, JS
White, MB
Burris, HA
机构
[1] Sarah Cannon Canc Ctr Tennessee Oncol, PLLC, Nashville, TN USA
[2] Jackson Oncol Associates, Jackson, MS USA
[3] No Virginia Oncol Grp PC, Fairfax, VA USA
[4] Graves Gilbert Clin, Bowling Green, KY USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
439
引用
收藏
页码:S113 / S113
页数:1
相关论文
共 50 条
  • [1] A randomized, phase II trial of weekly paclitaxel versus weekly paclitaxel plus carboplatin for first-line metastatic breast cancer.
    Robert, N
    Loesch, D
    Lindquist, D
    Ratnam, S
    Hyman, W
    Whittaker, T
    Logie, K
    Kruger, S
    Pippen, J
    Liu, L
    Goldstein, L
    Asmar, L
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S129 - S129
  • [2] Phase II trial of trastuzumab followed by weekly paclitaxel/carboplatin as first-line treatment for patients with metastatic breast cancer
    Burris, H
    Yardley, D
    Jones, S
    Houston, G
    Broome, C
    Thompson, D
    Greco, FA
    White, M
    Hainsworth, J
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (09) : 1621 - 1629
  • [3] Docetaxel and epirubicin as first-line treatment for patients with metastatic breast cancer: A minnie pearl cancer research network phase II trial
    Hainsworth, John D.
    Yardley, Denise A.
    Spigel, David R.
    Meluch, Anthony A.
    Rinaldi, David
    Schnell, Frederick M.
    Greco, F. Anthony
    CANCER INVESTIGATION, 2006, 24 (05) : 469 - 473
  • [4] Weekly paclitaxel, doxorubicin, and carboplatin in the first-line treatment of patients with metastatic breast cancer
    Hainsworth, JD
    Burris, HA
    Greco, FA
    SEMINARS IN ONCOLOGY, 1999, 26 (06) : 13 - 13
  • [5] First-line treatment of HER2-positive metastatic breast cancer (HER2+MBC) with trastuzumab, doectaxel and vinorelbine: results of a Minnie Pearl Cancer Research Network trial
    Yardley, Denise
    Greco, Anthony
    Porter, Lester L., III
    Burris, Howard A., III
    Phelps, Cindy
    Webb, Charles
    Schlabach, Larry
    Fichtel, Lisa
    Hainsworth, John D.
    ANNALS OF ONCOLOGY, 2004, 15 : 39 - 39
  • [6] Paclitaxel and mitoxantrone in the treatment of metastatic breast cancer: A phase II trial of the Minnie Pearl Cancer Research Network
    Hainsworth, JD
    Calvert, S
    Greco, FA
    CANCER INVESTIGATION, 2002, 20 (7-8) : 863 - 871
  • [7] Final results of first-line weekly paclitaxel plus gemcitabine in metastatic breast cancer (MBC): an AERO phase II trial
    Mousseau, M.
    Serin, D.
    Goubely-Brewer, Y.
    Petit, T.
    Priou, F.
    Zelek, L.
    BULLETIN DU CANCER, 2007, 94 (06) : 569 - 570
  • [8] Carboplatin, nab-paclitaxel and bevacizumab as first-line treatment for metastatic breast cancer.
    Lo, S. S.
    Guo, R.
    Czaplicki, K. L.
    Robinson, P. A.
    Gaynor, E.
    Barhamand, F. B.
    Schulz, W. C.
    Kash, J. J.
    Horvath, L. E.
    Bayer, R. A.
    Petrowsky, C.
    De la Torre, R.
    Park, J. H.
    Albain, K. S.
    CANCER RESEARCH, 2012, 72
  • [9] Weekly paclitaxel as first-line chemotherapy for elderly patients with metastatic breast cancer. A multicentre phase II trial
    ten Tije, AJ
    Smorenburg, CH
    Seynaeve, C
    Sparrebooma, A
    Schothorst, KLC
    Kerkhofs, LGM
    van Reisen, LGPM
    Stoter, G
    Bontenbal, M
    Verweij, J
    EUROPEAN JOURNAL OF CANCER, 2004, 40 (03) : 352 - 357
  • [10] Phase II trial of capecitabine and weekly paclitaxel as first-line therapy for metastatic breast cancer
    Blum, Joanne L.
    Dees, E. Claire
    Chacko, Aparna
    Doane, Lisa
    Ethirajan, Sukumar
    Hopkins, Judith
    McMahon, Richard
    Merten, Suzan
    Negron, Angel
    Neubauer, Marcus
    Ilegbodu, Des
    Boehm, Kristi A.
    Asmar, Lina
    O'Shaughnessy, Joyce A.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (27) : 4384 - 4390